Literature DB >> 9249147

Glycosylation of polyclonal and paraprotein IgG in multiple myeloma.

M Farooq1, N Takahashi, H Arrol, M Drayson, R Jefferis.   

Abstract

It has previously been shown that in multiple myeloma (MM) each IgG paraprotein exhibits a unique oligosaccharide profile. It has been assumed that this results from a clone specific glycosylation machinery. However, the abnormal physiological environment of the bone marrow in this disease may also affect normal plasma cells producing polyclonal IgG. We present data to show that this is so and that, in two cases, the oligosaccharide profile of the polyclonal IgG reflected that of the paraprotein from the same patient rather than that of normal polyclonal IgG.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249147     DOI: 10.1023/a:1018555619519

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  9 in total

Review 1.  In vitro antibodies: strategies for production and application.

Authors:  S L Morrison
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 2.  Glycosylation of recombinant proteins: problems and prospects.

Authors:  N Jenkins; E M Curling
Journal:  Enzyme Microb Technol       Date:  1994-05       Impact factor: 3.493

3.  Oligosaccharide-protein interactions in IgG can modulate recognition by Fc gamma receptors.

Authors:  J Lund; N Takahashi; J D Pound; M Goodall; H Nakagawa; R Jefferis
Journal:  FASEB J       Date:  1995-01       Impact factor: 5.191

4.  N-glycans of recombinant human interferon-gamma change during batch culture of chinese hamster ovary cells.

Authors:  A D Hooker; M H Goldman; N H Markham; D C James; A P Ison; A T Bull; P G Strange; I Salmon; A J Baines; N Jenkins
Journal:  Biotechnol Bioeng       Date:  1995-12-20       Impact factor: 4.530

5.  Glycosylation of human IgG subclass and mouse IgG2b heavy chains secreted by mouse J558L transfectoma cell lines as chimeric antibodies.

Authors:  J Lund; N Takahashi; S Hindley; R Tyler; M Goodall; R Jefferis
Journal:  Hum Antibodies Hybridomas       Date:  1993-01

6.  Effect of culture conditions on IgM antibody structure, pharmacokinetics and activity.

Authors:  B L Maiorella; J Winkelhake; J Young; B Moyer; R Bauer; M Hora; J Andya; J Thomson; T Patel; R Parekh
Journal:  Biotechnology (N Y)       Date:  1993-03

7.  Characterization of a recombinant antibody produced in the course of a high yield fed-batch process.

Authors:  D K Robinson; C P Chan; C Yu Lp; P K Tsai; J Tung; T C Seamans; A B Lenny; D K Lee; J Irwin; M Silberklang
Journal:  Biotechnol Bioeng       Date:  1994-09-05       Impact factor: 4.530

8.  A novel 13C isotopic labelling strategy for probing the structure and dynamics of glycan chains in situ on glycoproteins.

Authors:  A M Gilhespy-Muskett; J Partridge; R Jefferis; S W Homans
Journal:  Glycobiology       Date:  1994-08       Impact factor: 4.313

9.  Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs.

Authors:  J Lund; N Takahashi; H Nakagawa; M Goodall; T Bentley; S A Hindley; R Tyler; R Jefferis
Journal:  Mol Immunol       Date:  1993-06       Impact factor: 4.407

  9 in total
  6 in total

1.  Resistance of Neisseria meningitidis to human serum depends on T and B cell stimulating protein B.

Authors:  Maike G Müller; Nina E Moe; Phillip Q Richards; Gregory R Moe
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

2.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 3.  Glycosylation as a strategy to improve antibody-based therapeutics.

Authors:  Roy Jefferis
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

4.  Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR.

Authors:  Vesna Ilić; Nadezda Milosević-Jovcić; Sonja Petrović; Dragana Marković; Gordana Stefanović; Tatjana Ristić
Journal:  Glycoconj J       Date:  2008-01-11       Impact factor: 2.916

5.  Ku86 exists as both a full-length and a protease-sensitive natural variant in multiple myeloma cells.

Authors:  Charles A Gullo; Feng Ge; Geraline Cow; Gerrard Teoh
Journal:  Cancer Cell Int       Date:  2008-04-29       Impact factor: 5.722

6.  Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G.

Authors:  Willem Jan R Fokkink; David Falck; Tom C M Santbergen; Ruth Huizinga; Manfred Wuhrer; Bart C Jacobs
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.